002 — Rocky Mount, North Carolina

002 is a clinical research site located in Rocky Mount, North Carolina, United States 27804.

Crixeo Clinical Trials Trust Score: 9/100 (FAILING). This profile has not yet been claimed by the site owner.

002 has participated in 1 clinical trials with 1 currently active.

Therapeutic areas: Diabetic Foot Ulcer.

Sponsors: Cellution Biologics.

Is this your site?

Is this your site? Claim your profile and control the information sponsors and patients see.

Other research sites in Rocky Mount

Browse all research sites in North Carolina · View every site in Rocky Mount

• Nash General Hospital
• Nash Hospitals, Incorporated
• University of North Carolina NASH Cancer Center
• Emergency Care Center at Nash General Hospital, UNCHS
• PMG Research of Rocky Mount
• Research Site
• Boice-Willis Clinic
• GSK Investigational Site
• Accellacare of Rocky Mount
• Nash UNC HealthCare
• Boice Willis Clinic, PA
• Accellacare - Rocky Mount

Sponsor Feasibility Report

Trust Score: 9/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for 002?

002 has a Crixeo Trust Score of 9/100 (FAILING). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has 002 conducted?

002 has 1 clinical trials on record, with 1 currently active. Their work covers Diabetic Foot Ulcer.

Is 002 accredited by Crixeo Clinical Trials?

002 has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about 002?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.